Breakthrough Phase 2 Data: New Hope for Multiple System Atrophy Patients with ATH434 - Stock Titan
3 weeks ago • Google News
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Au.
3 weeks ago • Google News